Is there a link between DNA polymerase β and cancer?

Cell Cycle

Volumn 3, Issue 8, 2004, Pages 998-1001

  Starcevic, Daniela ^a   Dalal, Shibani ^a   Sweasy, Joann B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Base excision repair; Cancer; DNA polymerase ; Mutagenesis; Telomeres

Indexed keywords

DNA; DNA DIRECTED DNA POLYMERASE BETA; ENZYME VARIANT; LYSINE; METHIONINE; MUTANT PROTEIN;

ANIMAL CELL; CANCER; COLON CANCER; DNA SYNTHESIS; DRUG RESISTANCE; EXCISION REPAIR; GENE OVEREXPRESSION; GENETIC RECOMBINATION; GENETIC TRANSFORMATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MUTATOR PHENOTYPE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; TELOMERE; WILD TYPE;

EID: 13944279514     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Lang T, Maitra M, Starcevic D, Li SX, Sweasy JB. A DNA polymerase β mutant from colon cancer induces mutations. Proc Natl Acad Sci USA 2004; 101:6074-9.
2. Freidberg EC, Walker GC, Siede W. DNA repair and mutagenesis. Washington, DC: American Society for Microbiology, 1995.
3. Lindahl T. Instability and decay of the primary structure of DNA [see comments]. Nature 1993; 362:709-15.
4. Matsumoto Y, Kim K. Excision of deoxyribose phosphate residues by DNA polymerase β during DNA repair. Science 1995; 269:699-702.
5. Srivastava DK, Berg BJ, Prasad R, Molina JT, Beard WA, Tomkinson AE, Wilson SH. Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps. J Biol Chem 1998; 273:21203-9.
6. Sweasy JB. In: Moldavie K, ed. Elsevier, Orlando: Prog Nucleic Acid Res 2003:137-69.
7. Chou K, Cheng Y. An exonucleolytic activity of human apurinic/ apyrimidinic endonuclease on 3′ mispaired DNA. Nature 2002; 415:593-4.
8. Iwanaga A, Ouchida M, Miyazaki K, Hori K, Mukai T. Functional mutation of DNA polymerase β found in human gastric cancer-inability of the base excision repair in vitro. Mutation Res 1999; 435:121-8.
9. Wang L, Patel V, Ghosh L, Banerjee S. DNA polymerase β mutations in human colorectal cancer. Cancer Research 1992; 52:4824-4827.
10. Dobashi Y, Shuin T, Tsuruga H, Uemura H, Torigoe S, Kubota Y. DNA polymerase β gene mutation in human prostate cancer. Cancer Research 1994; 54:2827-9.
11. Bhattacharyya N, Chen HC, Comhair S, Erzurum SC, Banerjee S. Variant forms of DNA polymerase β in primary lung carcinomas. DNA Cell Biol 1999; 18:549-54.
12. Bhattacharyya N, Chen HC, Grundfest-Broniatowski S, Banerjee S. Alteration of hMSH2 and DNA polymerase β genes in breast carcinomas and fibroadenomas. Biochem Biophys Res Comm 1999; 259:429-35.
13. Miyamoto H, Miyagi Y, Ishikawa T, Ichikawa Y, Hosaka M, Kubota Y. DNA polymerase β gene mutation in human breast cancer. Int J Cancer 1999; 83:708-9.
14. Matsuzaki J, Dobashi Y, Miyamoto H, Ikeda I, Fujinami K, Shuin T, Kubota Y. DNA polymerase β gene mutations in human bladder cancer. Mol Carcinog 1996; 15:38-43.
15. Dong Z, Zhao G, Zhao Q, Yang H, Xue L, Tan X, Zheng N. A study of DNA polymerase β mutation in human esophageal cancer. Zhonghua Yi Xue Za Zhi 2002; 82:899-902.
16. Mohrenweiser HW, Xi T, Vazquez-Matias J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev 2002; 11:1054-64.
17. Kosa JL, Sweasy JB. The E249K mutator mutant of DNA polymerase β extends mispaired termini. J Biol Chem 1999; 274:35866-72.
18. Dalal S, Kosa JL, Sweasy JB. The D246V mutant of DNA polymerase β is a mutator due to altered positioning of the DNA within its active site. J Biol Chem 2004; 279:577-84.
19. Washington SL, Yoon MS, Chagovetz AM, Li SX, Clairmont CA, Preston BD, Eckert KA, Sweasy JB. A genetic system to identify DNA polymerase β mutator mutants. Proc Natl Acad Sci USA 1997; 94:1321-6.
20. Shah AM, Li SX, Anderson KS, Sweasy JB. Y265H mutator mutant of DNA polymerase β. Proper teometric alignment is critical for fidelity. J Biol Chem 2001; 276:10824-31.
21. Nowak R, Bieganowski P, Konopinski R, Siedlecki J. Alternative splicing of DNA polymerase β mRNA is not tumor specific. Int J Cancer 1996; 68:199-202.
22. Thompson TE, Rogan PK, Risinger JI, Taylor JA. Spice variants but not mutations of DNA polymerase β are common in bladder cancer. Cancer Res 2002; 62:3251-6.
23. Bhattacharayya N, Banerjee S. A variant of DNA polymerase β acts as a dominant negative mutant. Proc Natl Acad Sci USA 1997; 94:10324-9.
24. Bhattacharyya N, Banerjee S. A novel role of XRCC1 in the functions of a DNA polymerase β variant. Biochemistry 2001; 40:9005-13.
25. Sobol RW, Watson DE, Nakamura J, Yakes FM, Hou E, Horton JK, Ladapo J, Van Houten B, Swenberg JA, Tindall KR, Samson LD, Wilson SH. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc Natl Acad Sci USA 2002; 99:6860-5.
26. Srivastava DK, Husain I, Arteaga C, Wilson SH. DNA polymerase β expression differences in selected human tumors and cell lines. Carcinogenesis 1999; 20:1049-54.
27. Caldecott KW, Aoufouchi S, Johnson P, Shall S. XRCC1 polypeptide interacts with DNA polymerase β and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res 1996; 24:4387-94.
28. Zhou J, Ahn J, Wilson SH, Prives C. A role for p53 in base excision repair. EMBO J 2001; 20:914-23.
29. Fotiadou P, Henegariu O, Sweasy JB. DNA polymerase β interacts with TRF2 and induces telomere dysfunction in a murine mammary cell line. Cancer Res 2004; 64:3830-7.
30. Dianova II, Sleeth KM, Allinson SL, Parsons JL, Breslin C, Caldecott KW, Dianov GL. XRCC1-DNA polymerase β interaction is required for efficient base excision repair. Nucleic Acids Research 2004; 32:2550-2555.
31. Bergoglio V, Pillaire MJ, Lacroix-Triki M, Raynaud-Messina B, Canitrot Y, Bieth A, Gares M, Wright M, Delsol G, Loeb LA, Cazaux C, Hoffmann JS. Deregulated DNA polymerase β induces chromosome instability and tumorigenesis. Cancer Res 2002; 62:3511-4.
32. Clairmont CA, Narayanan L, Sun KW, Glazer PM, Sweasy JB. The Tyr-265-to-Cys mutator mutant of DNA polymerase β induces a mutator phenotype in mouse LN12 cells. Proc Natl Acad Sci USA 1999; 96:9580-5.
33. Loeb LA, Springgate CF, Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Research 1974; 34:2311-21.
34. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA 2003; 100:776-81.
35. Canitrot Y, Cazaux C, Frechet M, Bouayadi K, Lesca C, Salles B, Hoffmann JS. Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancer. Proc Natl Acad Sci USA 1998; 95:12586-90.
36. Eydmann ME, Knowles MA. Mutation analysis of 8p genes POLB and PPP2CB in baldder cancer. Cancer Genet Cytogenet 1997; 93:167-71.